GRAL's Q3 earnings should have benefited from rising Galleri test adoption, expanding digital health

TG Therapeutics (TGTX) possesses the right combination of the two key ingredients for a likely earni

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced initial results from the Company's Phase 1 stu

TG Therapeutics, Inc. (NASDAQ:TGTX), today announced initial results from the Company’s Phase 1 stud

NEW YORK--(BUSINESS WIRE)---- $TGTX--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced initial r

NEW YORK--(BUSINESS WIRE)---- $TGTX--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced several u

TG Therapeutics shares climb 59.9% in six months on strong Briumvi sales uptake, higher 2026 revenue

NEW YORK--(BUSINESS WIRE)---- $TGTX--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the publi

NEW YORK--(BUSINESS WIRE)---- $TGTX--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the sched

TG Therapeutics, Inc. (NASDAQ: TGTX - Get Free Report) shares passed above its 200-day moving averag

NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inve

Puma Biotechnology (NASDAQ: PBYI - Get Free Report) and TG Therapeutics (NASDAQ: TGTX - Get Free Rep

B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for th

TG Therapeutics NASDAQ: TGTX Chairman, President and Chief Executive Officer Mike Weiss said the com

California State Teachers Retirement System lifted its holdings in shares of TG Therapeutics, Inc. (

Fireside chat scheduled for Monday, September 14, 2026, at 12:00pm ET Fireside chat scheduled for Mo

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced th

TG Therapeutics (TGTX) reported earnings 30 days ago. What's next for the stock?

HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy

TG Therapeutics, Inc.'s Q4 2026/H1 2027 will be rich in catalysts. From the presentation of prelimin

Deutsche Bank AG purchased a new stake in TG Therapeutics, Inc. (NASDAQ: TGTX) in the undefined quar

Shares of TG Therapeutics rose this week after buyout rumors surfaced. TG is a prime takeover target

Dow Jones index gained around 350 points on Friday. MARA Holdings Inc (NASDAQ: MARA) rose sharply, w

Bank of America Corp DE lifted its position in TG Therapeutics, Inc. (NASDAQ: TGTX) by 71.7% in the

JP Morgan analyst Brian Cheng maintains TG Therapeutics (NASDAQ:TGTX) with a Overweight and raise

TG Therapeutics (NASDAQ:TGTX) raises FY2026 sales outlook from $925.000 million to $950.000 million

TG Therapeutics (NASDAQ:TGTX) reported quarterly earnings of $0.05 per share which missed the analys

B. Riley Securities analyst William Woods maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and

HC Wainwright & Co. analyst Emily Bodnar maintains TG Therapeutics (NASDAQ:TGTX) with a Buy a

B of A Securities analyst Alec Stranahan maintains TG Therapeutics (NASDAQ:TGTX) with a Underperf

HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial eval

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

TG Therapeutics shares are trading higher on Thursday as traders keep leaning into recent upbeat cli

3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, b

TG Therapeutics shares are trading higher on Wednesday as positive topline Phase 1 data fuels fresh

US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% afte

TGTX stock rises on positive Phase 1 data for subcutaneous BRIUMVI in myasthenia gravis. See what&#3

82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement in MG-ADL obser

82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement in MG-ADL obser

Shares of TG Therapeutics Inc (NASDAQ: TGTX) are climbing Wednesday after early-stage clinical trial

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY

Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen curre

TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the publication of data from a post-hoc pooled

HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy

Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the curren

TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the upcoming schedule of presentations highligh

HC Wainwright & Co. analyst Emily Bodnar maintains TG Therapeutics (NASDAQ:TGTX) with a Buy a

TG Therapeutics (NASDAQ:TGTX) reported quarterly earnings of $0.18 per share which missed the analys